Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma

Kilickap S., Yavuz B., Aksoy S., Sahiner L., Harputluoglu H., Dincer M., ...More

30th Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.202, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 17
  • City: İstanbul
  • Country: Turkey
  • Page Numbers: pp.202
  • Hacettepe University Affiliated: Yes